Agree on all points. The fact is that none of us need to do more research into how amazing Cymerus is.... Yamanka, Sluvkin, Fujifilm and Celularity have done that for us!
Placenta derived MSCs.... Same issue as MSB i.e Senescence during culture expansion /doubling. The fact is that Celularity needs Cymerus for mass production. Dr Hariri and the Celularity BoD are very very clever blokes and know whats up. Itescu/MSB won't admit it.......yet.
It's all coming together.
The value of Cymerus is colossal. It vastly more valuable than any first generation technology i.e TEMCELL bone-marrow MSCs or even Placenta derived MSCs.
Celularity is the key to Cymerus gaining HUGE HUGE PR coverage in the US. Then its going to go like an absolute rocket.
Celularity is so significant that I've almost forgotten about Fujifilm and the 90 day option period that is coming up soon. Crazy! surely we are half way through Cohort B.
The register is tight and becoming together. Soon whoever wants a large stake will have to pay a decent premium.
If anyone has CYP on their "watchlist" you better be careful otherwise you going to miss this one big time.
CYP Price at posting:
$1.18 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)